Interest in oxytocin has increased rapidly over the last decades. Consequently, quite a number of studies have addressed the influence of oxytocin on social stress, perception, cognition, and decision making in healthy adults as well as in clinical samples characterized by some form of social disturbance. Surprisingly little research on oxytocin has focused on ageing populations. This is particularly striking in two areas of study: the role of oxytocin in grandparents’ behavior toward and bonding with their grandchildren and the effects of oxytocin on the neurocognitive processing of socioemotional stimuli. The current mini-review offers an overview of the literature on the involvement of oxytocin in parental behavior and neurocognitive functioning, and discusses the relevance of these findings to ageing individuals. As the literature shows that oxytocin is profoundly involved in parenting and in bonding throughout life, it is highly likely that oxytocin plays a role in grandparenting and bonding between grandparents and grandchildren as well. However, results obtained with younger adults may not be directly applicable to older individuals in yet another type of relationship. The possibility that age-related changes occur in the oxytocin system (which is at present unclear) must be taken into account. In addition, ageing impairs neurocognitive processes that are profoundly affected by oxytocin (including some aspects of memory and emotion recognition) and is associated with alterations in both structure and function of the amygdala, which is prominently involved in mediating effects of oxytocin. Research investigating the ageing oxytonergic system and studies focusing on the involvement of oxytocin in socioemotional neurocognitive processes and social behavior in elderly individuals, including grandparents, are therefore urgently needed.

1.
MacDonald K, MacDonald TM: The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 2010;18:1–21.
2.
Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E: Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008;58:639–650.
3.
Huffmeijer R, Alink LRA, Tops M, Bakermans-Kranenburg MJ, Van IJzendoorn MH: Asymmetric frontal brain activity and parental rejection predict altruistic behavior: moderation of oxytocin effects. Cogn Affect Behav Neurosci 2012;2:382–392.
4.
Bakermans-Kranenburg MJ, Van IJzendoorn MH: Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Soc Cogn Affect Neursci 2008;3:128–134.
5.
Feldman R, Weller A, Zagoory-Sharon O, Levinde A: Evidence for a neuroendocrinological foundation of human affiliation. Psychol Sci 2007;18:965–970.
6.
Levine A, Zagoory-Sharon O, Feldman R, Weller A: Oxytocin during pregnancy and early postpartum: individual patterns and maternal-fetal attachment. Peptides 2007;28:1162–1169.
7.
Naber F, Van IJzendoorn MH, Deschamps P, Van Engeland H, Bakermans-Kranenburg MJ: Intranasal oxytocin increases fathers’ observed responsiveness during play with their children: a double-blind within-subject experiment. Psychoneuroendocrinology 2010;35:1583–1586.
8.
Bakermans-Kranenburg MJ, Van IJzendoorn MH, Riem MME, Tops M, Alink LRA: Oxytocin decreases handgrip force in reaction to infant crying in females without harsh parenting experiences. Soc Cogn Affect Neurosci, in press.
9.
Van IJzendoorn MH, Bakermans-Kranenburg MJ: A sniff of trust: meta-analysis of the effects of intranasal oxytocin on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinology 2011;37:438–443.
10.
Rehman HU, Masson EA: Neuroendocrinology of ageing. Age Ageing 2001;30:279–287.
11.
Allen JS, Bruss J, Brown CK, Damasio H: Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region. Neurobiol Ageing 2005;26:1245–1260.
12.
Holt-Lunstad J, Birmingham WA, Light KC: Influence of a ‘warm touch’ support enhancement intervention among married couples on ambulatory blood pressure, oxytocin, alpha amylase, and cortisol. Psychosom Med 2008;70:976–985.
13.
Feldman R, Gordon I, Zagoory-Sharon O: Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding. Dev Sci 2011;14:752–761.
14.
Gordon I, Zagoory-Sharon O, Leckman JF, Feldman R: Oxytocin and the development of parenting in humans. Biol Psychiatry 2010;68:377–382.
15.
Taylor SE, Gonzaga GC, Cousino Klein L, Hu P, Greendale GA, Seeman TE: Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosom Med 2006;68:238–245.
16.
Bartz JA, Zaki J, Ochsner KN, Bolger N, Kolevzon A, Ludwig N, Lydon JE: Effects of oxytocin on recollections of maternal care and closeness. Proc Natl Am Sci USA 2010;107:21371–21375.
17.
Bartz JA, Zaki J, Bolger N, Ochsner KN: Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 2011;15:301–309.
18.
Rimmele U, Hediger K, Heinrichs M, Klaver P: Oxytocin makes a face in memory familiar. J Neurosci 2009;29:38–42.
19.
Savaskan E, Ehrhardt R, Schulz A, Walter M, Schächinger H: Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 2008;33:368–374.
20.
Guastella AJ, Mitchell PB, Mathews F: Oxytocin enhances the encoding of positive social memories in humans. Biol Psychiatry 2008;64:256–258.
21.
Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A, Ochsner KN: Oxytocin selectively improves empathic accuracy. Psychol Sci 2010;21:1426–1428.
22.
Luminet O, Grynberg D, Ruzette N, Mikolajczak M: Personality-dependent effects of oxytocin: greater social benefits for high alexithymia scorers. Biol Psychol 2011;87:401–406.
23.
Guastella AJ, Mitchell PB, Dadds MR: Oxytocin increases gaze to the eye region of human faces. Biol Psychiatry 2008;63:3–5.
24.
Unkelbach C, Guastella AJ, Forgas JP: Oxytocin selectively facilitates recognition of positive sex and relationship words. Psychol Sci 2009;19:1092–1094.
25.
Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC: Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 2007;62:1187–1190.
26.
Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A: Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005;25:11489–11493.
27.
Gamer M, Zurowski B, Büchel C: Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc Natl Am Sci 2010;107:9400–9405.
28.
Domes G, Lischke A, Berger C, Grossmann A, Hauenstein K, Heinrichs M, Herpertz SC: Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010;35:83–93.
29.
Riem MME, Bakermans-Kranenburg MJ, Pieper S, Tops M, Boksem MAS, Vermeiren RRJM, Van IJzendoorn, MH, Rombouts SARB: Oxytocin modulates amygdala, insula and inferior frontal gyrus responses to infant crying: a randomized control trial. Biol Psychiatry 2011;70:291–297.
30.
Furman DJ, Chen MC, Gotlib IH: Variant in oxytocin receptor gene is associated with amygdala volume. Psychoneuroendocrinology 2011;36:891–897.
31.
Singer T, Snozzi R, Bird G, Petrovic P, Silani G, Heinrichs M, Dolan RJ: Effects of oxytocin and prosocial behavior on brain responses to direct and vicariously experienced pain. Emotion 2008;8:781–791.
32.
Ruffman T, Henry JD, Livingstone V, Phillips LH: A meta-analytic review of emotion recognition and ageing: implications for neuropsychologic models of ageing. Neurosci Biobehav Rev 2008;32:863–881.
33.
Calzà L, Pozza M, Coraddu F, Farci G, Giardino L: Hormonal influences on brain ageing quality: focus on corticotrophin releasing hormone-, vasopressin-, and oxytocin-immunoreactive neurons in the human brain. J Neural Transm 1997;104:1095–1100.
34.
Wierda M, Goudsmit E, Van der Woude PF, Purba JS, Hofman MA, Bogte H, Swaab DF: Oxytocin cell number in the human paraventricular nucleus remains constant with ageing and Alzheimer’s disease. Neurobiol Ageing 1991;12:511–516.
35.
North WG, Harbaugh R, Reeder T: An evaluation of human neurophysin production in Alzheimer’s disease: preliminary observations. Neurobiol Ageing 1992;13:261–265.
36.
Parker KJ, Hoffman CL, Hyde SA, Cummings CS, Maestripieri D: Effects of age on cerebrospinal fluid oxytocin levels in free-ranging adult female and infant rhesus macaques. Behav Neurosci 2010;124:428–433.
37.
Keck ME, Hatzinger M, Wotjak CT, Landgraf R, Holsboer F, Neumann ID: Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats. Eur J Neurosci 2000;12:1487–1494.
38.
Arsenijevic Y, Dreifuss JJ, Vallet P, Marguerat A, Tribollet E: Reduced binding of oxytocin in the rat brain during ageing. Brain Res 1995;698:275–279.
39.
Arletti R, Benelli A, Poggioli R, Luppi P, Menozzi B, Bertolini A: Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin. Neuropeptides 1995;29:177–182.
40.
St Jacques P, Dolcos F, Cabeza R: Effects of ageing on functional connectivity of the amygdala during negative evaluation: a network analysis of fMRI data. Neurobiol Ageing 2010;31:315–327.
41.
Wright CI, Dickerson BC, Feczko E, Negeira A, Williams D: A functional magnetic resonance imaging study of amygdala responses to human faces in ageing and mild Alzheimer’s disease. Biol Psychiatry 2007;62:1388–1395.
42.
Illum L: Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 2000;11:1–18.
43.
Mueller MM, Wilhelm B, Elder GH Jr: Variations in grandparenting. Res Ageing 2002;24:360–388.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.